Literature DB >> 1469163

Reversal of neurological deficit with naloxone: an additional report.

P Hans1, J F Brichant, E Longerstay, F Damas, J M Remacle.   

Abstract

We report the repeated improvement in neurological function following naloxone administration in a patient who developed acute hemiplegia after an intracranial neurological procedure. The mechanisms responsible for the neurological deficit and for its reversal by naloxone are discussed. A review of the literature suggests that the beneficial effect of naloxone can result from an improvement in haemodynamic status or from metabolic effects that could be favorable during cerebral ischaemia.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1469163     DOI： 10.1007/bf01694365

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  9 in total

1.  Does sufentanil exacerbate marginal neurological dysfunction?

Authors:  E C Benzel; T A Hadden; B D Nossaman; J Lancon; L Kesterson
Journal:  J Neurosurg Anesthesiol       Date:  1990-03       Impact factor: 3.956

2.  Naloxone: report of a beneficial side effect.

Authors:  S W Krechel; R M Orr; N B Couper; N Gupta; G W Eggers
Journal:  J Neurosurg Anesthesiol       Date:  1989-12       Impact factor: 3.956

3.  Naloxone reversal of ischaemic neurological deficits in man.

Authors:  D S Baskin; Y Hosobuchi
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

4.  Severe hypertension and multiple atrial premature contractions following naloxone administration.

Authors:  I Azar; H Turndorf
Journal:  Anesth Analg       Date:  1979 Nov-Dec       Impact factor: 5.108

5.  The effects of naloxone on cerebral blood flow and cerebral function during relative cerebral ischemia.

Authors:  J O Skarphedinsson; M Delle; P Hoffman; P Thorén
Journal:  J Cereb Blood Flow Metab       Date:  1989-08       Impact factor: 6.200

6.  Diagnosis of reversible versus irreversible cerebral ischemia by the intravenous administration of naloxone.

Authors:  B Estañol; F Aguilar; T Corona
Journal:  Stroke       Date:  1985 Nov-Dec       Impact factor: 7.914

7.  Failure of naloxone to improve spinal cord blood flow and cardiac output after spinal cord injury.

Authors:  M C Wallace; C H Tator
Journal:  Neurosurgery       Date:  1986-04       Impact factor: 4.654

8.  Effect of naloxone on cerebral perfusion and cardiac performance during experimental cerebral ischemia.

Authors:  R J Hariri; E L Supra; J P Roberts; M H Lavyne
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

9.  A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia.

Authors:  H P Adams; C P Olinger; W G Barsan; M J Butler; N R Graff-Radford; T G Brott; J Biller; H Damasio; T Tomsick; M Goldberg
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914
  9 in total
  5 in total

1.  Recrudescence of Old Stroke Deficits Among Transient Neurological Attacks.

Authors:  Adalia H Jun-O'connell; Nils Henninger; Majaz Moonis; Brian Silver; Carolina Ionete; Richard P Goddeau
Journal:  Neurohospitalist       Date:  2019-02-21

2.  Left-Right Side-Specific Neuropeptide Mechanism Mediates Contralateral Responses to a Unilateral Brain Injury.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Liliana Carvalho; Vladimir Galatenko; Igor Bazov; Nikolay Lukoyanov; Gisela H Maia; Mathias Hallberg; Mengliang Zhang; Jens Schouenborg; Georgy Bakalkin
Journal:  eNeuro       Date:  2021-05-25

3.  Ipsilesional versus contralesional postural deficits induced by unilateral brain trauma: a side reversal by opioid mechanism.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Mengliang Zhang; Linda Rorick-Kehn; Fredrik Clausen; Kinga Gawel; Jan Kehr; Mathias Hallberg; Jens Schouenborg; Niklas Marklund; Georgy Bakalkin
Journal:  Brain Commun       Date:  2020-12-13

Review 4.  The left-right side-specific endocrine signaling in the effects of brain lesions: questioning of the neurological dogma.

Authors:  Georgy Bakalkin
Journal:  Cell Mol Life Sci       Date:  2022-10-11       Impact factor: 9.207

5.  Recrudescence of Focal Stroke Symptoms during Pain Management with Hydromorphone.

Authors:  Joshua D Bernstock; Craig S Budinich; Leonardo G Cohen; Oluwole O Awosika
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.